Zobrazeno 1 - 10 of 13 pro vyhledávání: '"Pratima Kunwar"'
3
202 In vivo and in vitro characterization of AIM ACT, a novel nanoparticle-based technology, expanded MART-1 specific T cells
Autor: Ruipeng Wang, Daniel Dembrow, Emily Lu, Mathias Oelke, Pratima Kunwar, Sojung Kim, Lauren Suarez
Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundNexImmune is developing highly differentiated immunotherapies to target, activate and expand tumor antigen-specific T cells using the proprietary Artificial Immune Modulation (AIM™) nanotechnology platform. The AIM nanoparticle (AIM-np) t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67399f14ccdadb8fd53c4eedaa803913
https://doaj.org/article/9f288bbf76b84f9381f8264789481ce9
Zobrazit plný text záznamu
4
Akademický článek
Superior control of HIV-1 replication by CD8+ T cells targeting conserved epitopes: implications for HIV vaccine design.
Autor: Pratima Kunwar, Natalie Hawkins, Warren L Dinges, Yi Liu, Erin E Gabriel, David A Swan, Claire E Stevens, Janine Maenza, Ann C Collier, James I Mullins, Tomer Hertz, Xuesong Yu, Helen Horton
Publikováno v: PLoS ONE, Vol 8, Iss 5, p e64405 (2013)
A successful HIV vaccine will likely induce both humoral and cell-mediated immunity, however, the enormous diversity of HIV has hampered the development of a vaccine that effectively elicits both arms of the adaptive immune response. To tackle the pr
Externí odkaz: https://doaj.org/article/0cde32323f22454ab5a36aef4815d3be
Zobrazit plný text záznamu
5
97 High throughput screening of HPV-antigen peptides and expansion of tumor-specific T cells for adoptive cell therapy of HPV-associated malignancies
Autor: Lauren Suarez, Pratima Kunwar, Mathias Oelke, Jourdain Lemaster, Sojung Kim, David Langan
Publikováno v: Journal for ImmunoTherapy of Cancer. 9:A106-A106
BackgroundNexImmune is developing highly differentiated immunotherapies to target, activate and expand tumor antigen-specific T cells using the proprietary Artificial Immune Modulation (AIM™) nanotechnology platform. The AIM nanoparticle (AIM-np) t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::befa9d170b77914c8b8d357cf6cdeb43
https://doi.org/10.1136/jitc-2021-sitc2021.097
Zobrazit plný text záznamu
6
Novel Imidazoline Antimicrobial Scaffold That Inhibits DNA Replication with Activity against Mycobacteria and Drug Resistant Gram-Positive Cocci
Autor: Ramakrishna R. Juventhala, Pratima Kunwar, Michael S. Glickman, Nicholas D. Socci, Allison Fay, Narender Pottabathini, Hakim Djaballah, Han-Guang Yan, Kendra K. Harris
Publikováno v: ACS Chemical Biology
Bacterial antimicrobial resistance is an escalating public health threat, yet the current antimicrobial pipeline remains alarmingly depleted, making the development of new antimicrobials an urgent need. Here, we identify a novel, potent, imidazoline
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::feac66849d19cd3c7d489005198dc78b
https://doi.org/10.1021/cb500573z
Zobrazit plný text záznamu
8
Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials
Autor: Thormika Keo, Martin J. Blaser, Pratima Kunwar, Nicole M. Iovine, Jennifer Collins
Publikováno v: Virulence. 2(1)
The innate immune system plays a critical role in host defense against mucosal bacteria. Campylobacter jejuni is a major cause of human gastroenteritis that usually resolves spontaneously within several days, suggesting that innate mechanisms are imp
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99fea578a72ca0634eaecd08442c4cc7
https://pubmed.ncbi.nlm.nih.gov/21266840
Zobrazit plný text záznamu
9
Breadth or conservation score (CS): which is more important for HIV-1 T cell based vaccine immunogen design?
Autor: Helen Horton, Xuesong Yu, Tomer Hertz, Ann C. Collier, Pratima Kunwar, Natalie Hawkins, Yi Liu, Erin E. Gabriel
Publikováno v: Europe PubMed Central
Retrovirology
Retrovirology, Vol 9, Iss Suppl 2, p P260 (2012)
Background One of the greatest challenges to develop an efficacious HIV vaccine is the enormous diversity of HIV-1. To tackle this problem, T cells based vaccine approaches have come up with two main camps: the mosaic immunogen camp: increasing the b
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2281ac8abc6f8515510ccd46fed8bb4
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje